Bill > A05151

This bill requires any sponsor of a clinical trial in New York State that applies for a state grant, such as pharmaceutical manufacturers, academic medical centers, or health care providers, to publicly post detailed information about their clinical trial on the state department's website. The required information must include, to the extent permitted by federal law, comprehensive details such as the names and contact information of all trial sponsors, a summary of the trial's purpose, specific details about the pharmaceutical drug being tested (including active ingredients), the type and design of the clinical trial, its start and end dates, inclusion and exclusion criteria, treatment methods, hypotheses being tested, medical conditions under study, and potential adverse effects. Similarly, health care providers offering clinical trials must also post comparable information on their own websites. The bill aims to increase transparency in clinical research by ensuring that key information about medical studies is readily accessible to the public. The commissioner of the department is tasked with establishing rules for collecting and posting this information and monitoring compliance with these new requirements.

Health and Social Services

https://www.nysenate.gov/legislation/bills/2025/A5151